Vietnam Vaccine Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report (2026-2035)

Read more about this report -  REQUEST FREE SAMPLE COPY IN PDF

Vietnam Vaccine Market Overview

The market reached a value of approximately USD 3.93 Billion in 2025. The market is experiencing steady expansion driven by increasing immunization awareness, rising government vaccination programs, and growing focus on preventive healthcare. Strengthening healthcare infrastructure and expanded access to public immunization campaigns are supporting vaccine uptake across pediatric and adult populations. The market is also benefiting from international collaborations, improved cold-chain logistics, and the introduction of advanced vaccine technologies, including recombinant and mRNA platforms. The rising prevalence of infectious diseases and post-pandemic preparedness initiatives are further accelerating demand across both public and private healthcare systems.

Vietnam Vaccine Market Segmentation

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Read more about this report -  REQUEST FREE SAMPLE COPY IN PDF

Vietnam Vaccine Market Growth Analysis and Key Influencers

Vietnam Vaccine Market Dynamics

This section analyzes key factors influencing market growth, including strengthening national vaccination campaigns, rising demand for novel vaccines, improving cold chain logistics, increasing public health funding, and growing adoption of advanced immunization solutions.

Vietnam Vaccine Market Growth Drivers

Free HPV And Rota Vaccines Drive Vietnam Vaccine Market Growth

Rising childhood immunization needs, cervical cancer prevention, and affordability concerns are supporting market growth. For instance, in November 2025, Vietnam reported that HPV and Rota vaccines would be provided free under the national immunization program from 2026, with pneumococcal vaccination added through a phased rollout. The move should widen vaccine access during the forecast period, reduce out-of-pocket burden on families, and strengthen public-sector demand across pediatric, adolescent, and preventive health programs nationwide.

Vietnam Vaccine Market Restraints

Financing and Procurement Challenges Restrain Vietnam Vaccine Market

Expanding childhood immunization coverage, new vaccine inclusion plans, and wider preventive care demand support Vietnam’s vaccine sector, but financing gaps remain a market restraint. For instance, in February 2026, Duke Global Health Institute reported that Vietnam’s shift from international aid toward domestic immunization funding created policy and logistical challenges, including earlier shortages after provincial funding responsibility increased. This may slow rollout consistency during the forecast period, especially where local budgets, procurement planning, and cold-chain resources remain uneven.

Vietnam Vaccine Market Opportunities

Enterovirus Approval Advances Market Development for Pediatric Protection

High pediatric disease burden, unmet prevention needs, and stronger regulatory pathways are advancing Vietnam’s market development. For instance, in March 2026, Medigen Vaccine Biologics and Substipharm Biologics announced that ENVACGEN, an Enterovirus 71 vaccine, received authorization from Vietnam’s Drug Administration, becoming the country’s first approved vaccine for this indication. The approval should broaden pediatric protection during the forecast period, support specialist distribution partnerships, and encourage additional filings targeting infectious diseases with limited preventive options in Vietnam.

Vietnam Vaccine Market Trends

Next Generation Planning Expands Market Opportunities in Innovation

The government's focus on advanced care, biomedical innovation, and disease-prevention capacity is creating market opportunities. For instance, in May 2026, the government assigned the Ministry of Health to draft a list of next-generation vaccines for disease prevention and treatment, with completion scheduled for June. The initiative should guide future research priorities during the forecast period, attract technology partnerships, and support the development of modern platforms linked to outbreak preparedness and higher-value healthcare modernization across Vietnam.

Vietnam Vaccine Market Share

Viral Diseases Likely to Dominate the Market Segment by Disease Indication

The viral diseases accounted for nearly 48% market share in the historical period. The increasing government immunization initiatives, rising awareness regarding infectious disease prevention, and continuous expansion of vaccination programs are supporting demand across the country. Public health authorities are prioritizing protection against widespread viral infections through routine and targeted vaccination campaigns. Advancements in vaccine development and broader access to immunization services further strengthen adoption patterns. The viral diseases segment is likely to dominate the disease indication landscape, supported by sustained preventive healthcare efforts and evolving vaccination requirements.

Read more about this report -  REQUEST FREE SAMPLE COPY IN PDF

Leading Players in the Vietnam Vaccine Market

Key Questions Answered in the Vietnam Vaccine Market Report

• What was the Vietnam vaccine market value in 2025?
• What is the Vietnam vaccine market forecast outlook for 2026-2035?
• What major factors aid the demand for the Vietnam vaccine market?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major Vietnam vaccine market trends?
• Which product type is expected to dominate the vaccine market segment?
• Which vaccine type is expected to dominate the vaccine market segment?
• Which route of administration is expected to dominate the vaccine market segment?
• Which disease indication is expected to dominate the vaccine market segment?
• Which age group is expected to dominate the vaccine market segment?
• Which end user segment is expected to dominate the vaccine market?
• Who are the key players in the Vietnam vaccine market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

Research Methodology

This report is developed through a robust mixed-methods research design combining:

• Primary Research: Structured interviews with vaccine manufacturers, immunization program officials, pediatricians, public health specialists, procurement teams, cold-chain operators, hospital administrators, and distributors involved in vaccine access, supply, registration, and adoption across Vietnam.
• Secondary Research: Review of vaccine approvals, immunization program updates, procurement records, cold-chain policies, disease surveillance reports, company disclosures, regulatory notices, product literature, and government announcements covering vaccine supply, access, and adoption in Vietnam.
• Validation: All quantitative estimates are triangulated using top-down and bottom-up market modeling, validated through expert feedback loops.